Yue Luo
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway.
Journal: Frontiers in oncology
Published: October 25, 2024
Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma.
Journal: Biochemical pharmacology
Published: April 10, 2023
Comprehensive analysis of REST corepressors (RCORs) in pan-cancer.
Journal: Frontiers in cell and developmental biology
Published: February 09, 2023
Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC.
Journal: Biomedicines
Published: December 09, 2022
AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma.
Journal: Cancers
Published: August 25, 2022
Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma.
Journal: Frontiers in genetics
Published: April 08, 2022
LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma.
Journal: Canadian journal of gastroenterology & hepatology
Published: March 16, 2021
Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation.
Journal: Experimental & molecular medicine
Published: November 23, 2019
Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials.
Journal: BMC pharmacology & toxicology
Published: December 07, 2018
Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma.
Journal: Journal of Cancer
Published: April 30, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026